American Diabetes Association Standards of Medical Care in Diabetes 2017
- 13 March 2017
- journal article
- Published by Wiley in Journal of Diabetes
- Vol. 9 (4), 320-324
- https://doi.org/10.1111/1753-0407.12524
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2016
- Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care, 2016
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2016
- Pioglitazone after Ischemic Stroke or Transient Ischemic AttackNew England Journal of Medicine, 2016
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine, 2015
- The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging StudiesDiabetes Care, 2015